TCV has led a $200m round for online pharmacy Capsule, increasing the Virgin-backed company's total funding to $270m.

The Michelin and Wabco-backed in-car telematics technology developer has now raised at least $265m, following a $90m investment by TPG Sixth Street Partners.

Shin Nippon's migraine treatment spinoff, Satsuma Pharmaceuticals, floated above its range to raise $82.5m in an offering that follows $86m of funding.

Osage University Partners has celebrated an exit as migraine treatment developer Satsuma Pharmaceuticals listed on the Nasdaq Global Market following an $82.5m offering.

Chevron Technology Ventures and existing backer InMotion Ventures contributed to a round that increased the autonomous taxi developer's total funding to $52m.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

CAA Ventures-backed department store Neighborhood Goods has added $11m of series A capital to bring its total funding to $25.5m.

GSK’s co-investment partnership with Avalon Ventures has borne fruit with the acquisition of celiac treatment developer Sitari Pharmaceuticals.

Express Scripts is set to exit Mango Health having made a strategic investment in the health management app developer two years ago.

Replica, an urban planning technology startup spun off from Alphabet’s Sidewalk Labs subsidiary, has raised $11m in series A funding.